What is Parallel Fluidics?
Parallel Fluidics is revolutionizing scientific research by providing the world's first on-demand microfluidic manufacturing service. Their innovative approach allows scientific teams to obtain production-grade microfluidic devices from the initial stages of development, thereby mitigating the inherent risks and delays that often impede progress. By shortening the development cycle from concept to a viable microfluidic product, Parallel Fluidics empowers researchers to accelerate their discoveries and achieve improved patient outcomes. The company's technology is particularly impactful in fields such as diagnostics, drug discovery, precision medicine, sequencing, and cell therapy.
How much funding has Parallel Fluidics raised?
Parallel Fluidics has raised a total of $8.8M across 2 funding rounds:
Unspecified
$1.8M
Angel/Seed
$7M
Unspecified (2021): $1.8M, investors not publicly disclosed
Angel/Seed (2024): $7M led by Praxis, 8VC, and J2 Ventures
Key Investors in Parallel Fluidics
Praxis
Praxis is an investor in Parallel Fluidics, contributing to the company's strategic growth in the microfluidics sector.
8VC
8VC is a leading technology investment firm that backs visionary teams and industry-transforming companies, with a focus on smart enterprise platforms across various sectors including healthcare and Bio-IT.
J2 Ventures
J2 Ventures is an investment firm specializing in early-stage companies pioneering technologies in advanced computing and biomedical engineering, providing strategic value to founders.
What's next for Parallel Fluidics?
With the recent major strategic investment, Parallel Fluidics is poised for significant expansion and further innovation in the microfluidics sector. This capital infusion is expected to fuel the company's growth, enabling it to scale its on-demand manufacturing capabilities and enhance its service offerings. The strategic backing from investors like 8VC and J2 Ventures, known for their focus on transformative technologies in healthcare and advanced engineering, suggests a clear trajectory towards market leadership. Parallel Fluidics is likely to leverage this momentum to deepen its impact across life sciences, driving further breakthroughs and solidifying its position as a critical enabler of scientific advancement.
See full Parallel Fluidics company page
